Inventor
LEE SEUNG-JOO
US43 patents
⚠️ This page may combine multiple inventors who share the name “LEE SEUNG-JOO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALECTOR LLC
18 patentsUS10676525B2Jun 9, 2020
Anti-TREM2 antibodies and methods of use thereof
ALECTOR LLC13 citations84
US10711062B2Jul 14, 2020
Anti-CD33 antibodies and methods of use thereof
ALECTOR LLC7 citations83
US11254743B2Feb 22, 2022
Anti-CD33 antibodies and methods of use thereof
ALECTOR LLC2 citations72
US10800844B2Oct 13, 2020
Anti-Siglec-9 antibodies and methods of use thereof
ALECTOR LLC2 citations72
US11634489B2Apr 25, 2023
Anti-TREM2 antibodies and methods of use thereof
ALECTOR LLC2 citations71
US11136390B2Oct 5, 2021
Anti-CD33 antibodies and methods of use thereof
ALECTOR LLC3 citations71
US10590198B2Mar 17, 2020
Anti-siglec-7 antibodies and methods of use thereof
ALECTOR LLC2 citations70
US12226482B2Feb 18, 2025
Anti-SIRP-alpha antibodies and methods of use thereof
ALECTOR LLC0 citations62
US12004494B2Jun 11, 2024
Siglec transgenic mice and methods of use thereof
ALECTOR LLC0 citations62
US11779642B2Oct 10, 2023
Anti-SIRP-alpha antibodies and methods of use thereof
ALECTOR LLC1 citations62
US11667710B2Jun 6, 2023
Anti-Siglec-9 antibodies and methods of use thereof
ALECTOR LLC0 citations62
US11147249B2Oct 19, 2021
Siglec transgenic mice and methods of use thereof
ALECTOR LLC1 citations62
US12110327B2Oct 8, 2024
Anti-TREM1 antibodies and methods of use thereof
ALECTOR LLC0 citations61
US11470827B2Oct 18, 2022
Transgenic mice expressing human TREM proteins and methods of use thereof
ALECTOR LLC0 citations61
US11472877B2Oct 18, 2022
Anti-TREM1 antibodies and methods of use thereof
ALECTOR LLC0 citations61
US11390680B2Jul 19, 2022
Anti-Siglec-7 antibodies and methods of use thereof
ALECTOR LLC1 citations60
US12227568B2Feb 18, 2025
Anti-Siglec-7 antibodies and methods of use thereof
ALECTOR LLC0 citations51
US11897968B2Feb 13, 2024
Anti-MerTK antibodies and methods of use thereof
ALECTOR LLC0 citations51
BEAM THERAPEUTICS INC
5 patentsUS11142760B2Oct 12, 2021
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC14 citations93
US11344609B2May 31, 2022
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC6 citations84
US11155803B2Oct 26, 2021
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
BEAM THERAPEUTICS INC13 citations79
US11752202B2Sep 12, 2023
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC3 citations72
US12016908B2Jun 25, 2024
Compositions and methods for treating hemoglobinopathies
BEAM THERAPEUTICS INC0 citations61
EUTILEX CO LTD
4 patentsUS9862775B2Jan 9, 2018
Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof
EUTILEX CO LTD15 citations89
US10233254B2Mar 19, 2019
Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof
EUTILEX CO LTD4 citations70
US11072646B2Jul 27, 2021
Epitope for switching to TH1 cell and use thereof
EUTILEX CO LTD0 citations62
US11396555B2Jul 26, 2022
Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof
EUTILEX CO LTD0 citations59
SAMSUNG DISPLAY CO LTD
4 patentsUS10945340B2Mar 9, 2021
Method for manufacturing display device
SAMSUNG DISPLAY CO LTD3 citations71
US11523516B2Dec 6, 2022
Bending apparatus
SAMSUNG DISPLAY CO LTD0 citations61
US11570907B2Jan 31, 2023
Manufacturing apparatus for display device and method of using the same
SAMSUNG DISPLAY CO LTD0 citations58
US11096289B2Aug 17, 2021
Manufacturing apparatus for display device and method of using the same
SAMSUNG DISPLAY CO LTD0 citations58